AI assistant
Sending…
Forte Biosciences, Inc. — Director's Dealing 2017
Apr 17, 2017
33769_dirs_2017-04-17_71f486e8-661d-4527-9105-c496b08a8a88.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Tocagen Inc (TOCA)
CIK: 0001419041
Period of Report: 2017-04-15
Reporting Person: BERMAN DENNIS N (former director & officer)
More from Forte Biosciences, Inc.
Regulatory Filings
2026
Jun 2
Share Issue/Capital Change
2026
Jun 2
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 2
Earnings Release
2026
May 14
Capital/Financing Update
2026
Apr 9
Capital/Financing Update
2026
Apr 9
Capital/Financing Update
2026
Apr 8
Regulatory Filings
2026
Apr 1
Major Shareholding Notification
2026
Jan 29
Major Shareholding Notification
2026
Jan 20